A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C
The protein composition of an Outer Membrane Vesicle (OMV) preparation that constitutes the active pharmaceutical ingredient of VA-MENGOC-BC®, an effective vaccine against Neisseria meningitidis serogroups B, and C is presented. This preparation has a high lipid content and five abundant membrane pr...
Main Authors: | Yordanka Masforrol, Jeovanis Gil, Darien García, Jesús Noda, Yassel Ramos, Lázaro Betancourt, Osmany Guirola, Sonia González, Boris Acevedo, Vladimir Besada, Osvaldo Reyes, Luis Javier González |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2017.1356961 |
Similar Items
-
Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines
by: Emanuelle B. Gaspar, et al.
Published: (2021-09-01) -
Distribution of Serogroups and Genotypes among Neisseria Meningitidis Strains in Malaysia
by: Kuppusamy, Puvanesvari
Published: (2009) -
Estudio serológico y de protección en ratones utilizando diferentes esquemas y dosis de VA-MENGOC-BC®
by: Juan F. Infante, et al.
Published: (2001-06-01) -
Nueva generación de vacunas antimeningococica basadas en vesículas de membrana externa
by: Jan Poolman, et al.
Published: (2009-08-01) -
Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines
by: Helen Petousis-Harris, et al.
Published: (2019-04-01)